News
OPTIMA announce AstraZeneca and Mutabor as official partners
The Innovative Medicines Initiative (IMI) – a joint undertaking of the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA) – has announced the launch of the public-private research programme OPTIMA.